To establish if the humanized IgG1 CXCR4 antibody PF-06747143 and its parent antibody m15-IgG1 had comparable cell death activity, we performed a cell death study in leukemic B cells derived from B-CLL patient, comparing both antibodies. This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.